All Articles
Showing 121–132 of 223 articles.
Answering Key Questions from the Uspstf Evidence Review on PSA-Based Screening
The USPSTF concludes with moderate certainty that PSA-based screening for prostate cancer in men ages 55-69 offers a…
Read More →FDA Clearance Pathways and Evidence for Cardiovascular Wearables
The FDA evaluates consumer wearables that monitor for signs of atrial fibrillation through its Digital Health Center…
Read More →Accuracy and Real-World Performance of Consumer Wearables in Male Cardiovascular Monitoring
Large trials supported by NIH resources tested smartwatches for atrial fibrillation detection in daily life. One study…
Read More →FDA and CDC Clear Reformulated mRNA COVID-19 Vaccines for Fall 2024 Use
FDA Authorizes Updated 2024-2025 COVID-19 Vaccines Targeting KP.2 Lineage
Read More →Uspstf Updates Statin Guidance for Adults Ages 40–75 at Risk of Cardiovascular Disease
The U.S. Preventive Services Task Force updated its recommendation on statin use for primary prevention of…
Read More →FDA Labels, NEJM Trial Data, and NIH Findings on Semaglutide and Tirzepatide
Primary regulatory and clinical trial sources indicate that GLP-1 receptor agonists such as semaglutide produce…
Read More →What Recent NEJM Trial Data and Supporting Cohort Studies Show About HRT and Heart Risk
2023 TRAVERSE Trial Finds No Rise in Major Cardiovascular Events From Testosterone Therapy
Read More →FDA Detects Hidden PDE5 Inhibitors in OTC Male Enhancement Products
FDA Issues Safety Communication on Tainted Male Sexual Enhancement Supplements
Read More →Shorter Sleep Duration Consistently Linked to Lower Testosterone in Multiple Cohort Analyses
Observational Evidence Shows Association Between Shorter Sleep, Poor Sleep Quality, and Lower Testosterone in Adult Men
Read More →Multiple Trials Show Lean Mass Loss Alongside Fat Reduction in Obesity Treatments
Three trials published in The New England Journal of Medicine tracked body composition changes during treatment with…
Read More →Higher Weekly Physical Activity Levels Linked to Lower Mortality Risk in Men 40-65, Pooled Cohort Data Show
Cohort Studies Link Leisure-Time Physical Activity to Lower All-Cause Mortality Risk in Middle-Aged Men
Read More →What Pooled Research from Peer-Reviewed Journals Shows About Strength Training and Hormonal Health
Resistance Training Linked to Transient Testosterone Increases and Metabolic Improvements in Middle-Aged Men
Read More →